BBOT vs EW · $610.4M cap vs P/E 47, rev $1.39B
BridgeBio Oncology Therapeutics, Inc. (BBOT) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
BridgeBio Oncology Therapeutics, Inc. (BBOT) is a biotechnology company listed on NASDAQ.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
BBOT does not have a complete income-statement cache yet.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
BBOT currently screens at market cap $610.4M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the BBOT and EW stock pages for the full models.
Not investment advice.